Center for Genomic Science of IIT@SEMM, Istituto Italiano di Tecnologia (IIT), Via Adamello 16, 20139 Milan, Italy.
Cell Div. 2012 Feb 28;7(1):6. doi: 10.1186/1747-1028-7-6.
Activation of oncogenes is generally associated with the induction of DNA damage response (DDR) signaling, which acts as a barrier to tumor progression. In this review we will present an overview of the DDR associated with oncogenic activation of Myc, with special focus on two opposite and paradoxical aspects of this response: (1) the role of the Myc-induced DDR in tumor suppression; (2) its role in dampening Myc-induced replication stress, thereby protecting the viability of prospective cancer cells. These opposing effects on cancer progression are controlled by two different branches of DDR signaling, respectively ATM/CHK2 and ATR/CHK1. Indeed, while ATM activity constitutes a barrier to malignant transformation, full activation of ATR and CHK1 is essential for tumor maintenance, providing important opportunities for therapeutic intervention. Thus, the Myc-induced DDR acts as a double-edged sword in tumor progression.
癌基因的激活通常与 DNA 损伤反应 (DDR) 信号的诱导有关,该信号作为肿瘤进展的障碍。在这篇综述中,我们将介绍与 Myc 致癌激活相关的 DDR,特别关注该反应的两个相反和矛盾的方面:(1) Myc 诱导的 DDR 在肿瘤抑制中的作用;(2) 它在减轻 Myc 诱导的复制应激中的作用,从而保护潜在癌细胞的活力。这些对癌症进展的相反影响由 DDR 信号的两个不同分支分别控制,即 ATM/CHK2 和 ATR/CHK1。事实上,虽然 ATM 活性构成了恶性转化的障碍,但 ATR 和 CHK1 的完全激活对于肿瘤的维持是必不可少的,这为治疗干预提供了重要机会。因此,Myc 诱导的 DDR 在肿瘤进展中充当双刃剑。